The Precision Medicine Software Market is expected to grow at a CAGR 9% during the forecast period 2021-2026. Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market.
Request a Sample of this Report https://whipsmartmi.com/sample/he0381/Precision-Medicine-Software-Market
North America holds a significant share in the precision medicine software market during the forecast period. The large market share of North America in the precision medicine software market can be attributed to factors such as growing HCIT investments in the region, the presence of regulatory mandates supporting market growth in the US, and increasing digitalization and favorable funding initiatives by the Canadian government.

Key market players include Syapse, Inc. (US), 2bPrecise LLC (Israel), Foundation Medicine, Inc. (US), Fabric Genomics (US), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (US), N-of-One, Inc. (US), Human Longevity, Inc. (US), Translational Software, Inc. (US), Sunquest Information Systems Inc. (US), Gene42, Inc. (Canada), LifeOmic Health, LLC (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US), IBM Watson Group (US), and Koninklijke Philips N.V. (Netherlands).

View Complete Report https://whipsmartmi.com/sample/he0381/Precision-Medicine-Software-Market
View blogs: https://whipsmartmi.com/blogs
View Press Releases: https://whipsmartmi.com/pressrelease
Contact US: [email protected]